HIGHLIGHTS

• The US FDA has cleared Amplia's Investigational New Drug (IND) Application for a clinical trial of narmafotinib in the USA
• The proposed trial would explore the combination of narmafotinib and FOLFIRINOX in advanced pancreatic cancer patients in the USA

MELBOURNE, Australia, Jan. 18, 2024 /PRNewswire/ -- Amplia Therapeutics...